POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study
Digna T. de Bruin, Manon A. A. Jansen, Diana R. Pereira, Lisa van Schijndel,…